Noncoding RNA therapeutics — challenges and potential solutions

2021/06/18 by Melanie Winkle, Sherien M. El‐Daly, Sherien M. El-Daly +3 · 9 citations
Biochemistry, Genetics and Molecular Biology · #Cancer-related molecular mechanisms research #MicroRNA in disease regulation #RNA Interference and Gene Delivery

paper · pdf · doi:10.1038/s41573-021-00219-z

crossref issued 2021/06/18 · crossref published 2021/06/18 · crossref published-online 2021/06/18 · openalex publication_date 2021/06/18 · crossref created 2021/06/18 · crossref published-print 2021/08/01 · crossref deposited 2024/12/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29 · crossref indexed 2026/07/30

Cited by

• An i-motif-regulated enhancer, eRNA and adjacent lncRNA affect Lhb expression through distinct mechanisms in a sex-specific context
• Unraveling the Bivalent and Rapid Interactions Between a Multivalent RNA Recognition Motif and RNA: A Kinetic Approach
• History and future of RNA medicines
• Functional microRNA-targeting drug discovery by graph-based deep learning
• In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification
• An antagomiR-loaded β-peptide hydrogel promotes functional recovery in mice post-ischaemic stroke
• Epigenetic drugs in cancer therapy: mechanisms, immune modulation, and therapeutic applications
• Long non‐coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application
• Potential of oligonucleotide- and protein/peptide-based therapeutics in the management of toxicant/stressor-induced diseases